Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis.
Hofmann A, Krajnc N, Dal-Bianco A, Riedl CJ, Zrzavy T, Lerma-Martin C, Kasprian G, Weber CE, Pezzini F, Leutmezer F, Rommer P, Bsteh G, Platten M, Gass A, Berger T, Eisele P, Magliozzi R, Schirmer L, Hametner S. Hofmann A, et al. Among authors: leutmezer f. Acta Neuropathol. 2023 Nov;146(5):707-724. doi: 10.1007/s00401-023-02627-4. Epub 2023 Sep 16. Acta Neuropathol. 2023. PMID: 37715818 Free PMC article.
Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Bsteh G, Gradl C, Heschl B, Hegen H, Di Pauli F, Assar H, Leutmezer F, Traxler G, Krajnc N, Zulehner G, Hiller MS, Rommer P, Wipfler P, Guger M, Enzinger C, Berger T; AUT-MuSC investigators. Bsteh G, et al. Among authors: leutmezer f. Eur J Neurol. 2022 Jul 5:10.1111/ene.15488. doi: 10.1111/ene.15488. Online ahead of print. Eur J Neurol. 2022. PMID: 35791496 Free PMC article.
Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial.
Voggenberger L, Böck M, Moser D, Lorbeer G, Altmann P, Leutmezer F, Berger T, Seidel S. Voggenberger L, et al. Among authors: leutmezer f. Mult Scler J Exp Transl Clin. 2022 Nov 7;8(4):20552173221133262. doi: 10.1177/20552173221133262. eCollection 2022 Oct-Dec. Mult Scler J Exp Transl Clin. 2022. PMID: 36387033 Free PMC article.
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS.
Zrzavy T, Rieder K, Wuketich V, Thalhammer R, Haslacher H, Altmann P, Kornek B, Krajnc N, Monschein T, Schmied C, Zebenholzer K, Zulehner G, Berger T, Rommer P, Leutmezer F, Bsteh G. Zrzavy T, et al. Among authors: leutmezer f. Front Neurol. 2024 Apr 16;15:1388941. doi: 10.3389/fneur.2024.1388941. eCollection 2024. Front Neurol. 2024. PMID: 38689880 Free PMC article.
Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging.
Lipka A, Bogner W, Dal-Bianco A, Hangel GJ, Rommer PS, Strasser B, Motyka S, Hingerl L, Berger T, Leutmezer F, Gruber S, Trattnig S, Niess E. Lipka A, et al. Among authors: leutmezer f. Neuroimage Clin. 2023;40:103524. doi: 10.1016/j.nicl.2023.103524. Epub 2023 Oct 14. Neuroimage Clin. 2023. PMID: 37839194 Free PMC article.
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Kornek B, Krajnc N, Leutmezer F, Macher S, Rommer PS, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Pemp B, Berger T; for VMSD (Vienna Multiple Sclerosis Database) Group. Bsteh G, et al. Among authors: leutmezer f. Neurology. 2023 Aug 22;101(8):e784-e793. doi: 10.1212/WNL.0000000000207507. Epub 2023 Jul 3. Neurology. 2023. PMID: 37400245 Free PMC article.
Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).
Monschein T, Dekany S, Zrzavy T, Ponleitner M, Altmann P, Bsteh G, Kornek B, Rommer P, Enzinger C, Di Pauli F, Kraus J, Berger T, Leutmezer F, Guger M; Austrian MS Treatment Registry (AMSTR). Monschein T, et al. Among authors: leutmezer f. J Neurol. 2023 Aug;270(8):3787. doi: 10.1007/s00415-023-11784-1. J Neurol. 2023. PMID: 37272963 Free PMC article. No abstract available.
133 results